1. 2011 Multiple Sclerosis Curriculum Overall Metrics
August 28, 2012

2. Teva-Supported Multiple Sclerosis Curriculum
on Medscape Education Neurology
Dedicated landing page
Multiple specialty sites
6 original CME/CE activities

3. Teva-Supported 2011 Multiple Sclerosis Curriculum
on Medscape Education Neurology
Physicians
Allied Health
Activity
Launch Date
Learners
CME/ CE Test Takers
Neuros
PCPs
Total MDs
Nurses
PA/ NP
Total HCPs
Abstracts and Insights From the 2011 European Meeting in MS: Update on New Treatments, Clinical Aspects of MS, and Biomarkers
12/9/11
6,651
1,034
1,842
1,628
4,817
(161% of guarantee)
1,142
270
1,773
Lessons Learned From the 2011 European Meeting on MS
11/22/11
8,892
3,004
1,444
1,302
3,260
(109% of guarantee)
4,388
(439% of guarantee)
485
5,572
First Response From the 2011 European Meeting in Multiple Sclerosis
11/1/11
7,915
847
1,367
2,411
5,266
(176% of guarantee)
1,473
295
2,587
Lessons Learned From AAN 2011: Focus on Emerging Therapies for MS, Safety, and Adherence
5/12/11
11,228
3,566
1,924
2,606
4,938
(165% of guarantee)
5,127
(513% of guarantee)
614
6,215
Abstracts and Insights From AAN 2011: Update on Developments in MS Treatment
5/25/11
7,185
1,074
2,268
2,516
5,250
(175% of guarantee)
1,058
273
1,843
First Response From AAN 2011: Clinical Perspectives on MS
4/26/11
7,595
1,087
1,708
1,916
4,245
(142% of guarantee)
2,349
435
3,281
Advances in MS for the Improvement of Patient Outcomes
4/28/11
18,769
(375% of guarantee)
N/A
3,540
1,460
5,767
10,789
1,178
12,804
TOTALS - MS
68,235
10,612
14,093
13,839
33,543
26,326
3,550
34,075
Through July 31, 2012

4. Teva-Supported MS Curriculum on Medscape Education Neurology High Satisfaction (Average Across 6 Activities)
Through July 31, 2012

5. Teva-Supported MS Curriculum on Medscape Education Neurology Improved Performance (Average Across 6 Activities)
Through July 31, 2012

6. Teva-Supported MS Curriculum on Medscape Education Neurology Perceived Barriers to Improved Performance (Average Across 6 Activities)
Through July 31, 2012

7. (~71% of all patients with MS)
Does Effective Online Education Make a Difference? Estimated Impact of the Teva-Supported MS Curriculum on Patient Care
Factor
Projected Impact
Source/Calculation
Estimated number of Americans suffering from MS
400,000
WebMD
Estimated number of neurologists
13,366
AMA database
Average number of potential MS patients seen per clinician (estimated) 30
Total patients with MS/
estimated neurologists
Neurologist learners/interactions for the 5 activities (through July 31, 2012)
14,093
Medscape metrics report
An average of 76% of neurologist learners planned to make changes to their practice (modify their treatment plans and/or change their screening/prevention practice after participating in the activity), reflecting expected impact of the curriculum
10,711
89% of neurologist learners are very/somewhat committed to making changes
9,533
The number of patients with MS expected to have improved outcomes as a direct result of the Advances in MS for the Improvement in Patient Outcomes curriculum
285,975
(~71% of all patients with MS)
# of neurologist learners who are expecting to change their practice and are committed to making a change (9,533) x the average number patients with MS per neurologist (30)
Through July 31, 2012

8. Teva-Supported MS Curriculum on Medscape Education Neurology Cost Effective Education
Reach
Cost Per…
Readers
68,235
$0.07
per clinician reader
Neurologist Readers
14,093
$69.11
per neurologist reader
Patients
Estimated
285,975
~$3.40
per patient with improved outcomes
Through July 31, 2012

9. Teva-Supported MS Curriculum on Medscape Education Neurology Summary of Findings vs. Educational Goals
Goal
Finding
Strong reach to target audience members
Over 68,000 clinician learners to date
Includes over 14,000 neurologists learners
Strong impact on knowledge and behavior
Making a strong impact on their knowledge and behavior
76% of clinician learners planned to modify their treatment plans and/or change their screening/prevention practice after participating in the activity
89% of clinician learners are very/somewhat committed to making changes
Approximately 285,975 patients with MS receiving improved care
Be cost-effective
Extremely cost-effective
$0.07 per clinician learner
$69.11 per neurologist learner
$3.40 per patient with improved outcomes
Through July 31, 2012